Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

RAPT Therapeutics (RAPT) Treasury Shares: 2020-2023

Historic Treasury Shares for Therapeutics (RAPT) over the last 4 years, with Dec 2023 value amounting to $13,500.

  • Therapeutics' Treasury Shares fell 50.00% to $13,500 in Q4 2023 from the same period last year, while for Dec 2023 it was $13,500, marking a year-over-year decrease of 50.00%. This contributed to the annual value of $13,500 for FY2023, which is 50.00% down from last year.
  • Per Therapeutics' latest filing, its Treasury Shares stood at $13,500 for FY2023, which was down 50.00% from $27,000 recorded in FY2022.
  • Therapeutics' Treasury Shares' 5-year high stood at $56,500 during FY2020, with a 5-year trough of $13,500 in FY2023.
  • Its 3-year average for Treasury Shares is $27,000, with a median of $27,000 in 2022.
  • Data for Therapeutics' Treasury Shares shows a maximum YoY tumbled of 50.00% (in 2023) over the last 5 years.
  • Therapeutics' Treasury Shares (Yearly) stood at $56,500 in 2020, then dropped by 28.32% to $40,500 in 2021, then slumped by 33.33% to $27,000 in 2022, then crashed by 50.00% to $13,500 in 2023.